SCHEMBL26085136

SCHEMBL26085136

Cc1ccc(C2(OC(=O)C(C)(C)C(C)(C)C)CCCC2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HTR1E P28566 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ S1PR3 Q99500 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ DRD2 P14416 1/20 0.32
▸ DRD4 P21917 1/20 0.32
▸ DRD3 P35462 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ HSD11B1 P28845 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19753647 0.82 ADORA3 (0.39) OPRM1MAPTHTR1ENPSR1S1PR3
SCHEMBL25513876 0.82 MAPT (0.33) OPRM1MAPTHTR1ENPSR1S1PR3
SCHEMBL19753649 0.81 ADORA3 (0.41) OPRM1MAPTSMN1; SMN2KDM4EHPGD
SCHEMBL26152082 0.81 ADORA3 (0.34) OPRM1MAPTHTR1ENPSR1S1PR3
SCHEMBL26085137 0.80 ELANE (0.40) OPRM1MAPTHTR1ENPSR1S1PR3
SCHEMBL6202645 0.79 OPRM1 (0.38) OPRM1MAPTHTR1ENPSR1S1PR3
SCHEMBL26188242 0.78 ADORA3 (0.36) OPRM1MAPTHTR1ENPSR1S1PR3
SCHEMBL7915820 0.78 LMNA (0.40) OPRM1MAPTHTR1ENPSR1S1PR3
SCHEMBL26188243 0.77 ADORA3 (0.38) OPRM1MAPTSMN1; SMN2HPGDALDH1A1
SCHEMBL10062522 0.74 CA1 (0.38) OPRM1MAPTHTR1ENPSR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230314938-A1 CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230314938-A1 CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN HCAR1, H1-0, H1-10 OPRM1 204/4885MAPT 4708/4885HTR1E 2125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback